Diarrhoea, abdominal pain and feeling generally unwell – people showing these symptoms are often in a condition where there is inflammation in the gut. The Italian company SILA srl has now developed a new product, based on microencapsulated sodium butyrate with specific target-release at the heart of gut inflammation, for the treatment of human digestive system disorders.
SILA Srl
Publications on european-business
